Background
All organs and tissues in the body are continuously exposed to locally produced endogenous oxidants and aldehydes [
1,
2]. Oxidants are generated during normal physiological processes and are reactive intermediates capable of damaging cellular components [
1]. Aldehydes are the major end products of lipid peroxidation and can associate with proteins and nucleic acids to generate adducts, known to exert various harmful effects [
2]. Luckily, most cells produce antioxidants and aldehyde dehydrogenases (ALDHs), enabling them to keep these harmful products under control and minimize their deleterious effects [
3,
4]. Human lung, however, is additionally exposed to exogenous sources of oxidants and aldehydes from air pollution and cigarette smoke (CS). These factors seem to overwhelm lung defenses as aldehydes and oxidants in CS induce various harmful effects, including airway inflammation, cellular injury, DNA damage, and cytotoxicity [
5‐
7]. High levels of
ALDHs are observed in stem cells of many tissues and organs [
8], including the proximal airways [
9,
10]. The increased levels are considered to offer additional protection to stem cells against aldehydes. ALDH2 is one of the highest expressed ALDHs in the airways [
9,
10]
. ALDH2 concentration is prominently elevated in the bronchoalveolar lavage fluid of patients with chronic obstructive pulmonary disease (COPD) [
11]. The main substrate of ALDH2 is acetaldehyde, an intermediary product during ethanol metabolism. It functions mainly in the mitochondria, which are also an important source of reactive oxygen species (ROS). Furthermore, ALDH2 seems to function as an antioxidant as its overexpression provides protection from oxidative stress, while its deficiency augments the stress [
12,
13].
A single nucleotide polymorphism in
ALDH2 (termed
ALDH2*2), rs671, results in the amino acid change Glu478Lys. This mutant allele has a dominant-negative effect, resulting in the complete or near-complete loss of ALDH2 enzymatic activity in individuals who are homozygous or heterozygous for the
ALDH2*2 allele [
14]. This polymorphism is very common in East Asians and affects almost half of the population [
14]. Epidemiological and functional studies found that the
ALDH2*2 allele is associated with facial flushing and increased pulse rate upon alcohol consumption [
15], increased risk for cardiovascular diseases [
16], late-onset Alzheimer’s disease [
17], osteoporosis [
18], and several alcohol-related cancers, including oropharyngolaryngeal, esophageal, stomach, and colon cancers [
19].
However, despite distinctive lung exposure to both endogenous as well as exogenous aldehydes and oxidants, the effects of loss of ALDH2 function on the lungs of individuals with the ALDH2*2 polymorphism have not been studied extensively.
In this study, we extensively examined the effect of ALDH2 functional disturbance on lung histology and function in both humans and mice using in vitro and in vivo studies as well as a human genetic association study.
Methods
Human subjects for the genetic association study
To detect the overall effect of the
ALDH2 polymorphism on lung function in the general population, we conducted a cross-sectional association study on healthy volunteers (
n = 967). Longitudinal data were also assessed for the annual decline of forced expiratory volume in 1 s (FEV1) over at least four years (
n = 742). Additionally, to identify if the mutant allele is associated with the incidence of bronchial asthma or COPD, we genotyped a cohort of patients with bronchial asthma (
n = 751) and COPD (
n = 289) in comparison to the general population. Patients with bronchial asthma and COPD were recruited from the Tsukuba University Hospital and its affiliated hospitals [
20‐
22]. Recruitment of the healthy volunteers was carried out as described previously [
23]. They were recruited from the general population who visited the hospital for annual health checkups. Individuals with no evidence of pulmonary disease were included as healthy volunteers. Genomic DNA was extracted from the peripheral blood samples of all participants by an automated DNA extraction system (QuickGene-610 L; Fujifilm, Tokyo, Japan). Genotyping of patients with bronchial asthma and COPD was carried out by using the TaqMan Drug Metabolism Genotyping Assays. Genotyping of healthy volunteers was carried out by using the Illumina Human-Hap550v3 BeadChip assay (Illumina, San Diego, CA, USA) and the genotyping data of
ALDH2*2 (rs671) was extracted using PLINK version 1.07 [
23,
24]. Associations of the
ALDH2*2 genotype with lung function data in healthy volunteers were analyzed by linear regression models and were adjusted for age, sex and smoking status in PLINK version 1.07. Chi-square tests were used to analyze the association between the
ALDH2*2 genotype and the development of asthma and COPD.
Collection of epithelial cells from human lung and bronchial samples
Human surgical samples were collected from patients with a lung pathology that was clinically indicated for surgical removal. Fifteen samples were from a “lobectomy”, three were from a “pneumonectomy”, and six were from a “lung segment” removal. An apparently healthy lung portion away from the tumor and a portion from the bronchial stump were excised, shipped overnight on ice and were processed immediately upon receipt.
Small portions were used for DNA and RNA extraction, and for paraffin embedding for histological assessment. The remaining tissues were used for epithelial cell retrieval. The lung tissue was finely minced and incubated at 37 °C in 10 U/mL elastase (Porcine Pancreatic, Elastin Products Company, Owensville, MO, USA) for 30 min. The suspension was passed through an 18G needle using a large syringe to help disperse the tissue pieces into single cells. The cell suspension was then filtered through a 100-μm strainer to remove the undigested clumps. RBCs were depleted by adding 4 mL of ACK lysis buffer. Up to 500 μL of DNase (Sigma Aldrich, St. Louis, MO, USA) was added to the cell pellet. Then cells were incubated in 0.25% trypsin/EDTA at 37 °C for 20 min to obtain a single cell suspension. Hematopoietic and endothelial cells were then depleted using anti-human CD45 and CD31 microbeads on the autoMACS cell separation system (Miltenyi Biotec, Cologne, Germany). The cells were stained with an anti-human EpCAM antibody (BD Biosciences, Franklin Lakes, NJ, USA) and the epithelial cells were sorted on a MoFlo sorter. Non-epithelial cells were plated on plastic flasks in DMEM for 2 h to isolate the fibroblasts. Unattached cells were discarded and the fibroblasts were allowed to proliferate to >90% confluence, and were then frozen for future use in co-cultures.
The portions from bronchi were cleaned under a dissecting microscope and were cut open, followed by incubation in 50 U/mL dispase for 2 h at room temperature. Detached epithelial sheets were scrubbed off the inner surface and were incubated in 0.25% trypsin/EDTA at 37 °C for 30 min to obtain a single cell suspension. These cells were then referred to as primary human bronchial epithelial cells (HBECs), and cultured as such or stained for a basal cell marker (ITGA6, NGFR, or CD44) followed by sorting for basal cells.
In vitro 3D human organoid culture experiments
Bronchial epithelial cells were resuspended in MTEC/Plus medium and were mixed 2:1 with growth factor-reduced Matrigel (BD Biosciences). Lung cells were co-cultured with human lung fibroblasts in transwell inserts as previously described [
9,
10]
.
Some culture wells were treated with the ALDH2 activator, Alda-1 [
25] (Merck Millipore, Darmstadt, Germany), at 100–300 μM and/or H
2O
2 at 300–400 μM as a source of ROS. The growing colonies were imaged and were visually counted on day 14 and/or 21. Colonies in the inserts were either embedded in Histogel (Thermo Scientific, Waltham, MA, USA) followed by paraffin for histological assessment, or were digested with dispase and trypsin to single cells. Single cells were either passaged or were used for RNA extraction.
Genotyping of human surgical samples was conducted using 2 sets of PCR primers with DNA isolated from patient lung samples as previously described [
26]. Genotypes were further confirmed by the TaqMan® genotyping assay (TaqMan Drug Metabolism Genotyping Assays -ALDH2, Drug Metabolism Genotyping Assay mix, Life Technologies Corporation, Waltham, MA, USA).
qRT-PCR
mRNA expression of other lung-expressed ALDHs and several antioxidant genes was assessed by qRT-PCR. The following primers were used on a Step-One ABI cycler using SYBR green.
ALDH1A1: 5′-TGGCTGATTTAATCGAAAGAGAT-3′,
5′-TCCACCATTCATTGACTCCA-3′,
ALDH3A1: 5′-GGGAAGCAGGGTCCTTAAAT-3′,
5′-CGCTGATCTTGCTCATGG-3′,
HMOX-1: 5′-GGCAGAGGGTGATAGAAGAGG-3′,
5′-AGCTCCTGCAACTCCTCAAA-3′,
PRDX1: 5′-AGGCCTTCCAGTTCACTGAC-3′,
5′-CAGGCTTGATGGTATCACTGC-3′,
NQO1: 5′-CAGCTCACCGAGAGCCTAGT-3′,
5′-GAGTGAG CCAGTACGATCAGTG-3′,
NRF2: 5′-GCGACGGAAAGAGTATGAC-3′,
5′-GTTGGCAGATCCACTGGTTT-3′,
GAPDH: 5′- GAGTCAACGGATTTGGTCGT-3′,
5′-TTGATTTTGGAGGGATCTCG-3′.
Gene expression was expressed as ratios to GAPDH.
Western blotting
Small pieces of human lung samples were homogenized and lysed with cell lysis buffer and followed by measurement of protein concentrations. Equal amounts of protein were fractionated by electrophoresis and then transferred to PVDF membranes. The membranes were then incubated with antibodies against NRF2 (Santa Cruz), ALDH1A1 (Abcam), and ALDH3A1 (Santa Cruz) followed by incubation with secondary antibodies. For the detection of specific protein bands, the membranes were incubated in LumiGLO reagent and peroxide (Cell Signaling Technologies, Danvers, MA, USA), and then exposed to X-ray films.
Animals
We used two different types of mice with disturbed ALDH2 function;
Aldh2*2 transgenic (Tg) mice were generated by the pronuclear injection of a plasmid carrying mouse
Aldh2*2 cDNA with a single nucleotide mutation at the same position as that of the human
ALDH2*2 polymorphism, under the control of CAG promoter [
27] and
Aldh2
−/−
mice, in which the endogenous
Aldh2 gene is replaced by the neomycin-resistance gene [
28]. The wild type (WT) littermates were used as controls. Trachea and lung paraffin sections from WT,
Aldh2*2 Tg, and
Aldh2
−/−
mice were collected from newborn, adult, and aged mice and stained with hematoxylin and eosin (H&E). Tracheas were examined for epithelial thickness at 3 different locations. Because of natural variation in epithelial thickness between tracheal non-cartilaginous posterior portion and the rest of the circumference, and between uppermost and lowermost parts, we restricted our measurements and comparisons to the supracartilaginous regions of the sides of tracheal portion between cartilaginous rings 4 and 8. Four to six mice were analyzed per group. Nuclear densities were calculated by counting number of nuclei per a 100 μm. Quantification for percentage of cellular types in all groups was performed by counting from immunostained sections.
Immunostaining
Human surgical samples and mice samples were fixed with 4% paraformaldehyde and embedded in paraffin. Tissue sections (6-μm thickness) were prepared and immunostained as described previously [
29]. The primary antibodies used included rabbit K5 (Covance, Princeton, NJ, USA), goat CC10 (SCGB1A1) and Pro-surfactant protein C (SPC) (Santa Cruz Biotechnology), TTF1 (Abcam), mouse MUC5AC (Thermo Scientific), and mouse acetylated
β-tubulin (Sigma) for the identification of basal, club (Clara), alveolar type II, goblet, and ciliated cells. Interleukin (IL)-1β (Abcam), Gr-1 (BD), Peroxiredoxin 1 (Prdx1) (Abcam) and Hemagglutinin (Abcam) were used for characterization of the injury models. The appropriate Alexa-Fluor coupled secondary antibodies were used in double and triple stained sections. The nuclei were stained with DAPI and the slides were then examined by fluorescence microscopy using a Zeiss AxioImager microscope (Carl Zeiss).
Transmission electron microscopy (TEM)
Tracheas were cut between the 5th and 8th tracheal cartilaginous rings. All samples were fixed in 2.5% glutaraldehyde/0.1 M phosphate buffer (pH 7.4) for 2–4 h. After post-fixation in 1.5% osmium tetroxide/ 0.1 M phosphate buffer (pH 7.4) for 1 h, the samples were dehydrated in ethanol, treated with propylene oxide, then embedded in an epon resin, which was polymerized at 60 °C for 2–3 days. Semi-thin sections were stained with toluidine blue to select an optimal area of the epithelium with straight basement membrane and without artifacts. Ultra-thin sections were mounted on a nickel mesh and were electron-stained with uranyl acetate and lead citrate. The sections were then examined under a transmission EM, JEM 1400 (JEOE, Tokyo, Japan).
Mitochondrial functional assessments
Mouse tracheal epithelial cells (MTEC) were collected from at least 4
Aldh2
−/−
and WT mice. As this assay requires cells to be attached, extracellular flux 24-well culture plates (Seahorse Bioscience) were coated with 50 μg/mL collagen (BD Biosciences). These were then seeded in triplicates with 120,000 cell/well and were incubated for 2 days at 37 °C. The Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) were measured in all wells according to the manufacturer’s instructions (Seahorse Bioscience) and as described previously [
9,
30].
2-Examination of mitochondrial inner membrane protein
The mitochondrial membrane protein Tim23 (Santa Cruz Biotechnology) was examined by immunostaining of histological sections from mouse lung and tracheal tissues and in vitro colonies.
3-Measurment of ATP production
Using the CellTiter-Glo® Luminescent Cell Viability Assay (Promega, Fitchburg, WI, USA) in an opaque-walled 96 well plate, triplicate wells of serum-containing culture medium without cells, and a gradient of cell numbers from the lung and tracheal epithelium from the different mice were tested: 1000, 5000, 25,000, 50,000, and 100,000 cells in 100 μL vol according to the manufacturer’s protocol. Luminescence was recorded on a plate reader at 490 nm.
4-Quantification of functional mitochondria
MitoTracker® Red FM and/or MitoTracker® Red CMXRos (Promega) were used according to the manufacturer’s protocol. MTECs and lung cells were collected from WT, Aldh2*2 Tg, and Aldh2
−/−
mice. From each sample, 150,000 cells were stained in suspension, either examined by flow cytometry or cytospun, and examined by fluorescence microscopy.
5-Quantification of mitochondrial ROS levels
MitoSOX Red (Promega) was used according to the manufacturer’s protocol and 150,000 cells were stained and examined by flow cytometry or fluorescence microscopy.
The cells that were used for fluorescence microscopy analysis were cytospun onto glass slides. The cells were fixed by dispensing 100 μL of acetone onto the slide and allowed to air-dry. DAPI was then added to the cells. The cells were covered with a cover slip.
In vitro 3D mouse organoid culture experiments
Collection of MTEC and whole lung epithelium, isolation of lung fibroblasts and their co-culture in Matrigel were essentially performed as described previously [
29]. The medium used, treatment with H
2O
2 and/or Alda-1, quantification and processing of colonies at the end point were performed in a manner similar to the human organoid culture described above.
In vivo injury models
1-Chronic injury with CS
Ten adult
Aldh2*2 Tg mice and their WT littermates were exposed to mainstream CS using commercially available cigarettes (Marlboro, 12 mg tar/1.0 mg nicotine) as previously described [
31]. Exposure to 4% CS was given for one hour/day and 5 days/week for 16 weeks. Age-matched control mice for each group were exposed to air over the same period. Emphysema was assessed in the living animals by micro CT and after euthanasia on the histological sections, and was quantified using mean linear intercepts (Lm) [
31].
2-Acute injury with H1N1 influenza and polidocanol
Eight WT mice and seven Aldh2
−/−
mice were infected through the nose with a sub-lethal dose of influenza H1N1 PR8 (100 pfu/50 μL). Survival and body weight were recorded daily. The lungs were collected on day 8, embedded in paraffin, and the sections were stained with H&E and immunostained for epithelial and hematopoietic (inflammatory) cell markers like SPC, CC10, β-tubulin, and CD45. Viral load was assessed by staining for hemagglutinin.
Polidocanol has been previously used to induce acute injury of the airway epithelium. Ten microliters of 2% polidocanol were administered to mice anesthetized with ketamine/xylazine [
32]. However, in our hands, this dosing strategy resulted in more than 50% mortality. Thus, we performed preliminary experiments to optimize the administration technique. We optimized the route of administration (intra-nasal, intra-tracheal via oral intubation or through a neck incision), the device used for polidocanol delivery (insulin syringe or micro-sprayer), the volume of polidocanol (10, 15, and 20 μL), the concentration of polidocanol (0.5, 1, and 2%), the mode of anesthesia (ketamine i.p., isoflurane inhalation, combination of ketamine i.p. and isoflurane inhalation, isoflurane inhalation with continuous O
2), and the time points for sample collection (12 h, 24 h, 48 h, 5 days, and 7 days).
Statistics
Data from all samples from each group are expressed as mean ± SD. The quantification of CFE and cell types was performed by visual counting under a microscope and digital images from at least 3 triplicates and 3 independent experiments. T test was used for pairwise comparisons and a P value less than 0.05 was considered significant.
Discussion
In this study, we have examined the potential effects of the common loss-of-function polymorphism in the human ALDH2 gene on the lungs. We found that human carriers of the loss-of-function ALDH2*2 allele presented significantly lower FEV1/FVC than individuals who have the ALDH2/ALDH2 allele, but that was not accompanied with lower predicted FEV1%, faster rate of annual FEV1 decline, or asthma/COPD. The mechanism resulting in this isolated functional impairment remains unclear. However, our results suggest that, in addition to the ALDH2 loss of function, the presence of several other genetic and environmental influences is required to inflect a clinically observable obstructive lung disease.
We expected that the lung cells might compensate for lost ALDH2 function by upregulating other ALDHs and/or antioxidants. However, surprisingly,
NRF2, the key transcription factor regulating antioxidant gene expression, as well as one of the four antioxidant genes examined were significantly lower in the
ALDH2*2 human samples than in the
ALDH2 group, and no significant change was detected in the expression of other ALDHs. Previous studies suggested that the non-functional ALDH2*2 may inactivate not only ALDH2, but also other structurally-similar ALDHs by forming hetero-tetramers [
27]. Our results point to a previously unknown effect of the ALDH2 polymorphism, a negative effect on the antioxidant system.
In the mice experiments, we used two different types of mice that have some basic differences, which might explain some of the differences observed in their lung phenotypes.
Aldh2*2 Tg mice have smaller body size compared to
Aldh2
−/−
mice due to reduced muscle and fat masses. This suggests that the phenotypes observable in the
Aldh2*2 Tg mice are not caused by the simple lack of Aldh2 activity. It was suggested that the presence of the non-functional Aldh2*2 enzyme in the cell interferes with the ability of other Aldhs to detoxify aldehydes. Indeed, when the aldehyde reductase activity was compared between these two mice,
Aldh2
−/−
mouse displayed impaired Aldh activity only against acetaldehyde (as expected) and hexanal, while the
Aldh2*2 Tg mouse showed impaired Aldh activity against most aldehydes examined [
27]. We detected a histological abnormality in the tracheal epithelium in both
Aldh2*2 Tg and
Aldh2
−/−
mice. Interestingly, these abnormalities (thinning of the epithelium and decrease in cellular density most probably due to decrease in the number of basal cells) were not detectable at birth and only began to appear when the mice reached adulthood. Similar abnormalities (decrease in cellular density and basal cells) were recently described in old WT mice as “age-related changes” [
44]. Indeed, our aged WT mice also showed these age-related changes. Accordingly, the differences in their tracheal cellular density and basal cell ratio in comparison with those of old
Aldh2*2 Tg and
Aldh2
−/−
mice became insignificant. This suggests that the
Aldh2 loss-of-function polymorphism induced a kind of accelerated aging in the airway epithelium. Similar histological abnormality could not be identified in the human samples, probably because of the small number of samples examined and that all samples were from aged individuals who have been exposed to multiple environmental confounding factors.
Another significant finding of this study is the detection of several abnormalities in the mitochondria of
Aldh2*2 Tg and
Aldh2
−/−
mice. We detected a marked increase in morphologically abnormal mitochondria in the club and basal cells of
Aldh2
−/−
mice and a moderate increase in the
Aldh2*2 Tg adult mice. The number of these abnormal mitochondria was also moderately higher in aged WT mice than in the adult WT mice, again suggesting the premature appearance of aging-related changes as a result of Aldh2 loss. Mitochondrial function has long been recognized to decline during aging, concomitant with the appearance of alterations in mitochondrial morphology, e.g., abnormally rounded mitochondria in aged mammals [
45]. Therefore, on finding the morphologically abnormal mitochondria, we expected to also detect impairment of mitochondrial function. Thus, it was not surprising that the
Aldh2
−/−
tracheal and lung cells presented fewer (functional) mitochondria and higher mitochondrial ROS. However, the finding that
Aldh2*2 Tg mice have more mitochondria than the WT mice and showed no increase in mitochondrial ROS was both surprising and intriguing. The increase in the number of mitochondria and the upregulation of the antioxidant Prdx1 in
Aldh2*2 Tg mice might also explain its resistance to CS-induced emphysema compared to the WT mice. It is possible that the lung cells in these mice developed some sort of “tolerance” pathway to acclimatize to the absence of Aldh2 function, similar to the pathway described in the heart for cardioprotection against aldehydes [
27]. Further intensive investigations are needed to explain why the presence of non-functional Aldh2*2 in
Aldh2*2 Tg mice (but not the absence of Aldh2, as in
Aldh2
−/−
mice) results in such a differential effect on mitochondria. This points to the fact that results obtained from genetically engineered animals should not be automatically extrapolated to humans because pathological conditions in humans develop under the influence of an enormous unknown genetic and environmental variables.
To investigate a potential effect on stem cell function, we examined both airway and distal lung epithelium of both our mouse and human samples in our standardized in vitro CFE. No significant differences were detected among groups in mice or human, neither in the comparison of epithelial stem cells nor in their supportive (niche) fibroblast cells. This is similar to what has been described for the aging effect on mouse tracheal basal stem cells: despite the decrease in their number with age, in vitro CFE is preserved [
41].
Each injury model examined in this study showed a different trend. Chronic exposure to CS resulted in development of signs suggestive of emphysema in WT, but not in
Aldh2*2 Tg mice. The
ALDH2*2 allele is a risk factor for the development of many diseases and cancers [
16‐
19], especially when combined with alcohol consumption. On the other hand, it provides a protective effect against alcoholism and alcohol-induced diseases, obviously by inducing a behavioral change among individuals carrying the polymorphism causing them to abstain from alcohol consumption to avoid the unpleasant symptoms of flushing and severe hangovers [
46,
47]. However, a recent report suggested that the
ALDH2*2 allele provided an alcohol consumption-independent protection against vascular stenosis [
48]. In this study, CS exposure increased the lung volume in WT mice but not in
Aldh2*2 Tg mice. On the other hand, the CT value was increased in
Aldh2*2 Tg mice at 16 weeks. The same phenomenon was temporarily observed in WT mice until 12 weeks of CS, before development of emphysema in our previous study [
31]. These data imply that the
Aldh2*2 loss-of-function polymorphism protects against development of emphysema in response to chronic CS. More experiments are needed to elucidate the exact role of ALDH2 in the development of emphysema.
Further, there was no difference in the survival, body weight loss, inflammatory cell infiltration, and pneumonia between the WT and Aldh2
−/−
mice infected with H1N1 influenza virus. However, the Aldh2
−/−
mice displayed a more extensive loss of airway and lung parenchymal epithelium than the WT mice did. A genetic association study on a large number of individuals with influenza infection is needed to compare the severity of symptoms, the duration to recovery, and extent of lung damage between the patients with ALDH2 versus ALDH2*2 genotypes to confirm these animal findings.
Finally, no difference in repair efficiency was observed between the WT and the Aldh2*2 Tg or the Aldh2
−/−
mice following polidocanol injury. Collectively, the interaction and the role played by ALDH2 in the lung cells seems complex and the outcome depends on the cumulative interaction between the environment and the type of injuries/disease to which the lungs are exposed throughout the lifetime of the individual. Future studies are warranted to elucidate the interaction of ALDH2 enzyme and the environmental insults specific to the lung, like air pollution and CS, as well as ALDH2-specific insults associated with alcohol consumption.
Acknowledgements
We would like to thank Dr. Motoaki Sano and Dr. Shigeo Ohta for providing Aldh2*2 Tg mice, Dr. Takeshi Miyamoto and Dr. Toshihiro Kawamoto for providing ALDH2−/− mice, Dr. Kenji Kobayashi for advice on mitochondrial studies, and Dr. Yoji Andrew Minamishima for instructing flux analyzer experiment. We thank Mari Fujuwara, Miyuki Yamamoto, Mikiko Shibuya, Naomi Ishikawa, and Takako Nakamura for technical support and the Collaborative Research Resources, Keio University School of Medicine for technical support and reagents.